Wholesale and retail sale in Kazakhstan includes all prescription drugs registered in the state, as well as drugs with a registration certificate registered in the state.

Eurasian Economic Union as of January 15 and July 15 of this year - this list includes more than 6 thousand names of drugs.

The main goal of regulating the price of drugs is to prevent unjustified price increases, to ensure their economic availability for the population, as well as regardless of tenge exchange rate fluctuations and seasonal factors, to prevent a significant spread of the price of the same medicinal product both in the division of regions and among retail pharmacies. In addition, in order to expand the range of medicines on the market, a step-by-step price adjustment procedure will be carried out in Kazakhstan.

In the first stage, from the beginning of 2023, 302 names of over-the-counter drugs with three analogs and more than three manufacturers were released to the competitive environment.

In the second stage, in the second half of 2024, over-the-counter drugs with more than two analogs and manufacturers will be sold in the retail segment of the pharmaceutical market in the second half of 2024. 952 names of drugs for sale were issued.

In the first half of 2025, all drugs with more than 1,707 names are planned to be sent to the competitive environment.

In the third stage, by 2026, it is planned to spread the regulation to all drugs sold through the wholesale and retail network.

From 2026, only drugs purchased within the framework of the TMKKK and in the system of MASS will be subject to price regulation. will be.

Source : https://www.gov.kz/memleket/entities/dkmfk-vko/press/news/details/983300?lang=kk